Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Common Shares, without par value, of Arbutus Biopharma Corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: May 9, 2024
Whitefort Capital Master Fund, LP | |||
| By: | Whitefort Capital GP, LLC General Partner | ||
| By: | /s/ David Salanic | ||
| Name: | David Salanic | ||
| Title: | Co-Managing Member | ||
| By: | /s/ Joseph Kaplan | ||
| Name: | Joseph Kaplan | ||
| Title: | Co-Managing Member | ||
Whitefort Capital GP, LLC | |||
| By: | /s/ David Salanic | ||
| Name: | David Salanic | ||
| Title: | Co-Managing Member | ||
| By: | /s/ Joseph Kaplan | ||
| Name: | Joseph Kaplan | ||
| Title: | Co-Managing Member | ||
| Whitefort Capital Management, LP | |||
| By: | /s/ David Salanic | ||
| Name: | David Salanic | ||
| Title: | Co-Managing Partner | ||
| By: | /s/ Joseph Kaplan | ||
| Name: | Joseph Kaplan | ||
| Title: | Co-Managing Partner | ||
| Whitefort Capital Management GP, LLC | |||
| By: | /s/ David Salanic | ||
| Name: | David Salanic | ||
| Title: | Co-Managing Member | ||
| By: | /s/ Joseph Kaplan | ||
| Name: | Joseph Kaplan | ||
| Title: | Co-Managing Member | ||
/s/ David Salanic | |
| David Salanic |
/s/ Joseph Kaplan | |
| Joseph Kaplan |
